Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › High capacity recombinant adenoviral vector for treatment of hemophilia A

High capacity recombinant adenoviral vector for treatment of hemophilia A

US Patent 7238346 · Granted Jul 3, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adenovirus comprising a modified adenovirus hexon protein2025
Muscle-specific nucleic acid regulatory elements and methods and use thereof2025
Muscle-specific nucleic acid regulatory elements and methods and use thereof2025
Muscle-specific nucleic acid regulatory elements and methods and use thereof2025
Liver-specific nucleic acid regulatory elements and methods and use thereof2025
Liver-specific nucleic acid regulatory elements and methods and use thereof2025
Life-cycle-defective adenovirus helper viruses, their production and use for pro2024
Muscle-specific nucleic acid regulatory elements and methods and use thereof2024
Muscle-specific nucleic acid regulatory elements and methods and use thereof2024
Diaphragm-specific nucleic acid regulatory elements and methods and use thereof2024
Liver-specific nucleic acid regulatory elements and methods and use thereof2023
Liver-specific nucleic acid regulatory elements and methods and use thereof2023